1 completed, 1 terminated, 1 withdrawn. 3 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 1, Terminated 1, Withdrawn 1 |
| Phase 2 | 1 | Withdrawn 1 |
Follow MM-151: new trials by email Literature Review of MM-151 trials Research Report on MM-151
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluation of MM-151 + Nal-IRI + 5-FU + Leucovorin in RAS/RAF Wild-type Metastatic Colorectal Cancer MM-151, nal-IRI, Leucovorin - Colorectal Cancer | Phase 1 / Phase 2 | Withdrawn | Merrimack Pharmaceuticals | 2016-07-01 | 2017-01-11 | |
| Phase 1 Combination Study of MM-151 With MM-121, MM-141, or Trametinib MM-151, MM-121, MM-141 - Colorectal Cancer, Non-small Cell Lung Cancer | Phase 1 | Terminated | Merrimack Pharmaceuticals | 5 | 2015-08-01 | 2017-09-05 |
| Safety Study of the Drug MM-151 in Patients With Advanced Solid Tumors Resisting Ordinary Treatment MM-151, MM-151 + irinotecan - Advanced Solid Tumors, Colorectal Cancer | Phase 1 | Completed | Merrimack Pharmaceuticals | 112 | 2012-01-01 | 2018-03-21 |
Colorectal Neoplasms (3) · Neoplasms (3) · Carcinoma, Non-Small-Cell Lung (2) · Head and Neck Neoplasms (1) · Squamous Cell Carcinoma of Head and Neck (1) · Triple Negative Breast Neoplasms (1)
United States (2)